The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $298.10 million. The enterprise value is $374.06 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 98.38 million shares outstanding. The number of shares has increased by 15.14% in one year.
| Current Share Class | 98.38M |
| Shares Outstanding | 98.38M |
| Shares Change (YoY) | +15.14% |
| Shares Change (QoQ) | +4.58% |
| Owned by Insiders (%) | 8.15% |
| Owned by Institutions (%) | 36.27% |
| Float | 84.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | 0.51 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.68
| Current Ratio | 1.68 |
| Quick Ratio | 1.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.90 |
Financial Efficiency
Return on equity (ROE) is -4,132.17% and return on invested capital (ROIC) is -22.35%.
| Return on Equity (ROE) | -4,132.17% |
| Return on Assets (ROA) | -14.99% |
| Return on Invested Capital (ROIC) | -22.35% |
| Return on Capital Employed (ROCE) | -41.93% |
| Revenue Per Employee | $558,835 |
| Profits Per Employee | -$66,308 |
| Employee Count | 825 |
| Asset Turnover | 2.69 |
| Inventory Turnover | 27.10 |
Taxes
| Income Tax | -131,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,376.61% in the last 52 weeks. The beta is 0.19, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +1,376.61% |
| 50-Day Moving Average | 3.75 |
| 200-Day Moving Average | 2.87 |
| Relative Strength Index (RSI) | 40.30 |
| Average Volume (20 Days) | 3,103,698 |
Short Selling Information
The latest short interest is 4.45 million, so 4.52% of the outstanding shares have been sold short.
| Short Interest | 4.45M |
| Short Previous Month | 4.79M |
| Short % of Shares Out | 4.52% |
| Short % of Float | 5.24% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, TOI had revenue of $461.04 million and -$54.70 million in losses. Loss per share was -$0.64.
| Revenue | 461.04M |
| Gross Profit | 68.31M |
| Operating Income | -41.11M |
| Pretax Income | -66.41M |
| Net Income | -54.70M |
| EBITDA | -34.09M |
| EBIT | -41.11M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $27.66 million in cash and $103.62 million in debt, giving a net cash position of -$75.97 million or -$0.77 per share.
| Cash & Cash Equivalents | 27.66M |
| Total Debt | 103.62M |
| Net Cash | -75.97M |
| Net Cash Per Share | -$0.77 |
| Equity (Book Value) | -12.27M |
| Book Value Per Share | -0.13 |
| Working Capital | 44.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.63 million and capital expenditures -$3.90 million, giving a free cash flow of -$27.53 million.
| Operating Cash Flow | -23.63M |
| Capital Expenditures | -3.90M |
| Free Cash Flow | -27.53M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 14.82%, with operating and profit margins of -8.92% and -14.38%.
| Gross Margin | 14.82% |
| Operating Margin | -8.92% |
| Pretax Margin | -14.40% |
| Profit Margin | -14.38% |
| EBITDA Margin | -7.39% |
| EBIT Margin | -8.92% |
| FCF Margin | n/a |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.14% |
| Shareholder Yield | -15.14% |
| Earnings Yield | -18.35% |
| FCF Yield | -9.23% |
Analyst Forecast
The average price target for TOI is $6.00, which is 98.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 98.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of 0.59 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.59 |
| Piotroski F-Score | 4 |
